These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36403760)

  • 1. Intracoronary transplantation of pluripotent stem cell-derived cardiomyocytes: Inefficient procedure for cardiac regeneration.
    Kobayashi H; Tohyama S; Kanazawa H; Ichimura H; Chino S; Tanaka Y; Suzuki Y; Zhao J; Shiba N; Kadota S; Narita K; Naito T; Seto T; Kuwahara K; Shiba Y; Fukuda K
    J Mol Cell Cardiol; 2023 Jan; 174():77-87. PubMed ID: 36403760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Kobayashi H; Tohyama S; Ichimura H; Ohashi N; Chino S; Soma Y; Tani H; Tanaka Y; Yang X; Shiba N; Kadota S; Haga K; Moriwaki T; Morita-Umei Y; Umei TC; Sekine O; Kishino Y; Kanazawa H; Kawagishi H; Yamada M; Narita K; Naito T; Seto T; Kuwahara K; Shiba Y; Fukuda K
    Circulation; 2024 Aug; 150(8):611-621. PubMed ID: 38666382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of Pluripotent Stem Cell-Derived Cardiomyocytes into a Myocardial Infarction Model of Cynomolgus Monkey.
    Kobayashi H; Ichimura H; Ohashi N; Shiba Y
    Methods Mol Biol; 2021; 2320():295-302. PubMed ID: 34302666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart regeneration using pluripotent stem cells.
    Kadota S; Tanaka Y; Shiba Y
    J Cardiol; 2020 Nov; 76(5):459-463. PubMed ID: 32690435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent Stem Cell-Derived Cardiomyocyte Transplantation for Heart Disease Treatment.
    Kadota S; Shiba Y
    Curr Cardiol Rep; 2019 Jun; 21(8):73. PubMed ID: 31228011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluripotent stem cell-based cardiac regenerative therapy for heart failure.
    Soma Y; Tani H; Morita-Umei Y; Kishino Y; Fukuda K; Tohyama S
    J Mol Cell Cardiol; 2024 Feb; 187():90-100. PubMed ID: 38331557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spheroids of cardiomyocytes derived from human-induced pluripotent stem cells improve recovery from myocardial injury in mice.
    Mattapally S; Zhu W; Fast VG; Gao L; Worley C; Kannappan R; Borovjagin AV; Zhang J
    Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H327-H339. PubMed ID: 29631371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study.
    Fan C; Fast VG; Tang Y; Zhao M; Turner JF; Krishnamurthy P; Rogers JM; Valarmathi MT; Yang J; Zhu W; Zhang J
    J Mol Cell Cardiol; 2019 Dec; 137():25-33. PubMed ID: 31629738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust Cardiac Regeneration: Fulfilling the Promise of Cardiac Cell Therapy.
    Selvakumar D; Clayton ZE; Chong JJH
    Clin Ther; 2020 Oct; 42(10):1857-1879. PubMed ID: 32943195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models.
    Yu JK; Liang JA; Franceschi WH; Huang Q; Pashakhanloo F; Sung E; Boyle PM; Trayanova NA
    Cardiovasc Res; 2022 Mar; 118(5):1247-1261. PubMed ID: 33881518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Grown Micro-Tissues for Cardiac Cell Replacement Therapy in Vivo.
    Sahito RGA; Sheng X; Maass M; Mikhael N; Hamad S; Heras-Bautista CO; Derichsweiler D; Spitkovsky D; Suhr F; Khalil M; Brockmeier K; Halbach M; Saric T; Hescheler J; Krausgrill B; Pfannkuche K
    Cell Physiol Biochem; 2019; 52(6):1309-1324. PubMed ID: 31050280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
    Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
    Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative transcriptional signatures for evaluating the maturity degree of pluripotent stem cell-derived cardiomyocytes.
    Chen R; He J; Wang Y; Guo Y; Zhang J; Peng L; Wang D; Lin Q; Zhang J; Guo Z; Li L
    Stem Cell Res Ther; 2019 Mar; 10(1):113. PubMed ID: 30925936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy.
    Cho GS; Lee DI; Tampakakis E; Murphy S; Andersen P; Uosaki H; Chelko S; Chakir K; Hong I; Seo K; Chen HV; Chen X; Basso C; Houser SR; Tomaselli GF; O'Rourke B; Judge DP; Kass DA; Kwon C
    Cell Rep; 2017 Jan; 18(2):571-582. PubMed ID: 28076798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular heterogeneity of pluripotent stem cell-derived cardiomyocyte grafts is mechanistically linked to treatable arrhythmias.
    Selvakumar D; Clayton ZE; Prowse A; Dingwall S; Kim SK; Reyes L; George J; Shah H; Chen S; Leung HHL; Hume RD; Tjahjadi L; Igoor S; Skelton RJP; Hing A; Paterson H; Foster SL; Pearson L; Wilkie E; Marcus AD; Jeyaprakash P; Wu Z; Chiu HS; Ongtengco CFJ; Mulay O; McArthur JR; Barry T; Lu J; Tran V; Bennett R; Kotake Y; Campbell T; Turnbull S; Gupta A; Nguyen Q; Ni G; Grieve SM; Palpant NJ; Pathan F; Kizana E; Kumar S; Gray PP; Chong JJH
    Nat Cardiovasc Res; 2024 Feb; 3(2):145-165. PubMed ID: 39196193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concise Review: Reduction of Adverse Cardiac Scarring Facilitates Pluripotent Stem Cell-Based Therapy for Myocardial Infarction.
    Liang J; Huang W; Jiang L; Paul C; Li X; Wang Y
    Stem Cells; 2019 Jul; 37(7):844-854. PubMed ID: 30913336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
    Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
    PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
    Tan SH; Loo SJ; Gao Y; Tao ZH; Su LP; Wang CX; Zhang SL; Mu YH; Cui YH; Abdurrachim D; Wang WH; Lalic J; Lim KC; Bu J; Tan RS; Lee TH; Zhang J; Ye L
    Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
    Wendel JS; Ye L; Tao R; Zhang J; Zhang J; Kamp TJ; Tranquillo RT
    Stem Cells Transl Med; 2015 Nov; 4(11):1324-32. PubMed ID: 26371342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluripotent Stem Cells for Cardiac Regeneration　- Current Status, Challenges, and Future Perspectives.
    Shiba Y
    Circ J; 2020 Nov; 84(12):2129-2135. PubMed ID: 33087630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.